InvestorsObserver
×
News Home

Where Does Rocket Pharmaceuticals Inc (RCKT) Stock Fall in the Biotechnology Field After It Is Down -2.28% This Week?

Monday, March 04, 2024 12:30 PM | InvestorsObserver Analysts

Mentioned in this article

Where Does Rocket Pharmaceuticals Inc (RCKT) Stock Fall in the Biotechnology Field After It Is Down -2.28% This Week?

Rocket Pharmaceuticals Inc (RCKT) is around the top of the Biotechnology industry according to InvestorsObserver. RCKT received an overall rating of 70, which means that it scores higher than 70 percent of all stocks. Rocket Pharmaceuticals Inc also achieved a score of 82 in the Biotechnology industry, putting it above 82 percent of Biotechnology stocks. Biotechnology is ranked 12 out of the 148 industries.

Overall Score - 70
RCKT has an Overall Score of 70. Find out what this means to you and get the rest of the rankings on RCKT!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Rocket Pharmaceuticals Inc Stock Today?

Rocket Pharmaceuticals Inc (RCKT) stock is down -4.65% while the S&P 500 is higher by 0.04% as of 12:29 PM on Monday, Mar 4. RCKT has fallen -$1.42 from the previous closing price of $30.53 on volume of 266,524 shares. Over the past year the S&P 500 is up 26.94% while RCKT is higher by 41.52%. RCKT lost -$2.92 per share the over the last 12 months. Click Here to get the full Stock Report for Rocket Pharmaceuticals Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App